Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses

被引：0

作者：

Comi, Giancarlo ^{[1
,2
]}

Carra, Adriana ^{[3
]}

Fazekas, Franz ^{[4
]}

Rieckmann, Peter ^{[5
]}

Bajenaru, O. ^{[6
]}

Hillert, Jan ^{[7
]}

Elovaara, Irina ^{[8
]}

Young, Carolyn ^{[9
]}

Wynn, Daniel ^{[10
]}

King, John ^{[11
]}

Lubetzki, Catherine ^{[12
]}

Hartung, Hans-Peter ^{[13
]}

Myhr, Kjell-Morten ^{[14
]}

Montalban, Xavier ^{[15
]}

Komoly, Samuel ^{[16
]}

Filippi, Massimo ^{[17
]}

机构：

[1] Ist Sci San Raffaele, I-20132 Milan, Italy

[2] Univ Vita Salute, Dept Neurol, Milan, Italy

[3] Hosp Britan, Buenos Aires, DF, Argentina

[4] Med Univ Graz, Graz, Afghanistan

[5] Univ Bristish Columbia & Vancouver Coastal Hlth, Vancouver, BC, Canada

[6] Carol Davila Univ Med & Pharm, Bucharest, Romania

[7] Karolinska Univ Hosp, Stockholm, Sweden

[8] Univ Tampere, FIN-33101 Tampere, Finland

[9] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England

[10] Neurol Multiple Sclerosis Ctr, Northbrook, IL USA

[11] Royal Melbourne Hosp, Melbourne, Vic, Australia

[12] Hop La Pitie Salpetriere, Paris, France

[13] Univ Dusseldorf, Dusseldorf, Germany

[14] Haukeland Hosp, N-5021 Bergen, Norway

[15] Hosp Univ Vall dHebron, Barcelona, Spain

[16] Univ Pecs, Budapest, Hungary

[17] Ist Sci San Raffaele, I-20132 Milan, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2008年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S38 / S38

页数：1

共 50 条

[41] CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis
Tumani, H.
Lehmensiek, V.
Rau, D.
Guttmann, I.
Tauscher, G.
Mogel, H.
Palm, C.
Hirt, V.
Suessmuth, S. D.
Sapunova-Meier, I.
Ludolph, A. C.
Brettschneider, J.
NEUROSCIENCE LETTERS, 2009, 452 (02) : 214 - 217
[42] Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
Brettschneider, J
Petzold, A
Junker, A
Tumani, H
MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (02) : 143 - 148
[43] CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis
Brettschneider, J.
Lehmensiek, V.
Hirt, V.
Rau, D.
Tumani, H.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S201 - S201
[44] Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study
Kolcava, Jan
Kocica, Jan
Hulova, Monika
Dusek, Ladislav
Horakova, Magda
Kerkovsky, Milos
Stulik, Jakub
Dostal, Marek
Kuhn, Matyas
Vlckova, Eva
Bednarik, Josef
Benesova, Yvonne
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
[45] Prediction of early conversion to multiple sclerosis in clinically isolated syndrome
Cinar, B. Piri
Ozakbas, S.
Idiman, E.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 59 - 60
[46] High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
de Vries, Roos M. van der Vuurst
Wong, Yu Yi M.
Mescheriakova, Julia Y.
van Pelt, E. Danielle
Runia, Tessel F.
Jafari, Naghmeh
Siepman, Theodora A. M.
Melief, Marie-Jose
Wierenga-Wolf, Annet F.
van Luijn, Marvin M.
Samijn, Johnny P.
Neuteboom, Rinze F.
Hintzen, Rogier Q.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 958 - 967
[47] MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry
Bendfeldt, Kerstin
Taschler, Bernd
Gaetano, Laura
Madoerin, Philip
Kuster, Pascal
Mueller-Lenke, Nicole
Amann, Michael
Vrenken, Hugo
Wottschel, Viktor
Barkhof, Frederik
Borgwardt, Stefan
Kloeppel, Stefan
Wicklein, Eva-Maria
Kappos, Ludwig
Edan, Gilles
Freedman, Mark S.
Montalban, Xavier
Hartung, Hans-Peter
Pohl, Christoph
Sandbrink, Rupert
Sprenger, Till
Radue, Ernst-Wilhelm
Wuerfel, Jens
Nichols, Thomas E.
BRAIN IMAGING AND BEHAVIOR, 2019, 13 (05) : 1361 - 1374
[48] The comparison of McDonald 2005, McDonald 2010 and Swanton criteria for prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis
Cinar, B. Piri
Ozakbas, S.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 60 - 60
[49] MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry
Kerstin Bendfeldt
Bernd Taschler
Laura Gaetano
Philip Madoerin
Pascal Kuster
Nicole Mueller-Lenke
Michael Amann
Hugo Vrenken
Viktor Wottschel
Frederik Barkhof
Stefan Borgwardt
Stefan Klöppel
Eva-Maria Wicklein
Ludwig Kappos
Gilles Edan
Mark S. Freedman
Xavier Montalbán
Hans-Peter Hartung
Christoph Pohl
Rupert Sandbrink
Till Sprenger
Ernst-Wilhelm Radue
Jens Wuerfel
Thomas E. Nichols
Brain Imaging and Behavior, 2019, 13 : 1361 - 1374
[50] Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes - Reply
Kappos, L.
Polman, C. H.
Freedman, M. S.
Edan, G.
Hartung, H. -P.
Miller, D. H.
Montalban, X.
Barkhof, F.
Bauer, L.
Pohl, C.
Sandbrink, R.
NEUROLOGY, 2007, 68 (14) : 1163 - 1164

← 1 2 3 4 5 →